Physician Resources

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Publish date: August 25, 2014

 

References

Clinical Algorithm(s)
Clinical algorithms are provided in the original guideline document for the following:
  • 2012 American College of Rheumatology (ACR) recommendations update for the treatment of early rheumatoid arthritis (RA), defined as a disease duration <6 months
  • 2012 ACR recommendations update for the treatment of established RA, defined as a disease duration ≥6 months or meeting the 1987 ACR classification criteria
  • 2012 ACR recommendations update for tuberculosis (TB) screening with biologic agent use

Pages

Recommended Reading

VIDEO: Does obesity’s effect on RA support different treatment goals?
MDedge Rheumatology
Long-acting–opioid prescribing rate highest in Maine
MDedge Rheumatology
Patients become full partners in inflammatory arthritis and psoriasis research
MDedge Rheumatology
Telecare intervention lessens chronic joint pain
MDedge Rheumatology
As severity of rheumatoid arthritis rises, so does risk of preterm delivery
MDedge Rheumatology
Higher risk of progression found in joints with subclinical joint inflammation on MRI
MDedge Rheumatology
Age, income, ethnicity predicted rheumatoid arthritis drug discontinuation
MDedge Rheumatology
Link between autoimmune therapy, preterm birth is largely due to confounding
MDedge Rheumatology
Guidelines, quality indicators found lacking for CVD in RA
MDedge Rheumatology
No rise in breast cancer recurrence found with TNF inhibitor use
MDedge Rheumatology